Guzip Biomarkers Corporation - Taipei, Taiwan

Guzip Biomarkers Corporation is a research-driven spin-out company from Taipei Medical University, established in 2018. Our focus is to develop novel DNA methylation epigenetic biomarkers for clinical applications. Our foremost aim is to create a health management system for personalized medicine, and to make a positive contribution to women's health. To this end, we are developing a groundbreaking molecular diagnostic test known as MPap™ DNA Methylation Detection Kit, which can be used to detect endometrial cancer.